Help
Subscribe


GastroHep.com - the global online resource for all aspects of gastroenterology, hepatology and endoscopy

 23 February 2017

Advanced search
GastroHep.com - the global online resource for all aspects of gastroenterology, hepatology and endoscopy Profile of Roy Pounder

Home

News  
Journals
Review Articles
Slide Atlas
Video Clips
Online Books
Advanced Digestive Endoscopy
Classical Cases
Conference Diary
PubMed
International GH Links
USA GH Links
National GH Links
National GI Societies
Other Useful Links




Emails on Gastroenterology and Hepatology
the National AIDS Treatment Advocacy Project
Visit the gastroenterology section of the EUMS

News

Effect of the GABAB agonist baclofen on symptoms of GERD

The GABAB agonist baclofen reduces 24 hour gastro-esophageal reflux and increases gastric pH in patients with GERD, finds a research team in the April issue of Gut.

News image

fiogf49gjkf04

The gamma-aminobutyric acid (GABAB) agonist baclofen reduces reflux episodes in the first 3 postprandial hours. This occurs in both patients with gastro-esophageal reflux disease (GERD) and in normal controls.

In this study, researchers from Italy assessed acute and chronic administration of baclofen on 24-hour pH metry and symptoms in GERD patients and normal controls.

In the acute study, the team assessed 28 patients with GERD, and none or mild esophagitis at endoscopy. They also assessed 15 controls.

Baclofen or placebo were administered for 24 hours in a double blinded manner.

In the acute study, gastric pH increased significantly in both groups.
Gut

Subjects underwent esophageal and gastric 48-hour pH metry.

In the chronic study, 16 GERD patients received baclofen (10 mg 4 times daily) or placebo for 4 weeks.

The team evaluated 24-hour esophageal pH metry and reflux symptom scores before and after treatment.

In the acute study, researchers found that the number of reflux episodes and percent of time with pH < 4 was significantly lower after baclofen in both GERD patients and controls.

In addition, gastric pH increased significantly in both groups.

In the chronic study, the team found that 4 weeks after initial administration of baclofen, the number of reflux episodes and percentage of time with pH < 4 significantly decreased in all GERD patients.

In addition, symptom scores significantly improved after treatment with baclofen.

Profs. Ciccaglione and Marzio concluded, "The GABAB agonist baclofen reduces 24 hour gastro-esophageal reflux and increases gastric pH in GERD patients and controls".

"When given for 1 month to GERD patients, baclofen reduces esophageal acid refluxes and significantly improves symptoms."

"Baclofen may be useful in the therapy of GERD."

Gut 2003; 52: 464-70
14 March 2003

Go to top of page Email this page Email this page to a colleague

 23 February 2017 
Safer interval elective surgery for adults with Crohn's
 23 February 2017 
Quality of care for GERD 
 23 February 2017 
Video games in covert hepatic encephalopathy
 23 February 2017 
Video games in covert hepatic encephalopathy
 22 February 2017 
Confocal laser endomicroscopy for gastric cancer
 22 February 2017 
Predicting response to corticosteroids in severe alcoholic hepatitis
 22 February 2017 
Gluten exposure in celiac disease
 21 February 2017 
Cancer survival in Lynch syndrome 
 21 February 2017 
Motor peripheral nerve injury after colorectal surgery
 21 February 2017 
Anesthetics during outpatient gastroenterology procedures
 20 February 2017 
Advanced neoplasms with low-risk adenomas
 20 February 2017 
Concepts of cirrhotic coagulopathy
 20 February 2017 
Smoking at diagnosis and colon cancer survival
 17 February 2017 
Genetic mutations predict esophageal cancer
 17 February 2017 
Genetic mutations predict esophageal cancer
 17 February 2017 
Anesthesia services during outpatient gastroenterology procedures
 16 February 2017 
Hysterectomy and pelvic floor disorders
 16 February 2017 
Anesthetist-directed sedation in endoscopic procedures
 16 February 2017 
Assisted reproduction in women with IBD 
 15 February 2017 
Metal stents for palliation in malignant biliary obstruction
 15 February 2017 
Hepatocellular carcinoma in the USA
 15 February 2017 
Increasing screening of cirrhosis in hepatocellular carcinoma
 14 February 2017 
Pathologists agreement in the diagnosis of Barrett's
 14 February 2017 
Preventive care in IBD 
 14 February 2017 
Infliximab dose for acute severe ulcerative colitis
 13 February 2017 
Vasoactive drugs for hepatorenal syndrome type 1
 13 February 2017 
Pregnancy outcomes after endoscopy
 13 February 2017 
H. pylori treatment guidelines
 10 February 2017 
Primary ileocecal resection in pediatric Crohn's disease
 10 February 2017 
Non-adherence in end-stage liver disease
 10 February 2017 
Isolated colonic Crohn's disease
 09 February 2017 
Mucosal healing in ulcerative colitis
 09 February 2017 
NAFLD and coronary artery calcium score
 09 February 2017 
Prevalence of Hep D in chronic Hep B infection
 08 February 2017 
Rifaximin for small intestine bacterial overgrowth
 08 February 2017 
Risk prediction of interval cancers from inadequate colonoscopy quality
 08 February 2017 
Meta-analyses in gastroenterology and hepatology journals
 07 February 2017 
Chemoprevention in colon cancer
 07 February 2017 
Untreated hepatocellular carcinoma in the USA
 07 February 2017 
Methotrexate intolerance in pediatric IBD 
 06 February 2017 
Vitamin D levels and risk of relapse in ulcerative colitis
 06 February 2017 
Giardia in the USA
 06 February 2017 
Colorectal cancer risk in serrated polyposis syndrome
 03 February 2017 
Helicobacter and Campylobacter in IBD
 03 February 2017 
Mortality risk in elderly-onset IBD
 03 February 2017 
Management of chronic refractory pouchitis
 02 February 2017 
IBD-related research and publications
 02 February 2017 
TWEAK in IBD
 02 February 2017 
Clostridium difficile and colectomy risk in IBD
 01 February 2017 
Suboptimal bowel preparation in outpatient colonoscopy
 01 February 2017 
Fecal microbiota transplantation
 01 February 2017 
Socio-economic distribution of IBD 
 31 January 2017 
Gastroenterology fellowship
 31 January 2017 
Approach to Lynch syndrome
 31 January 2017 
Fat intake and ulcerative colitis risk
 30 January 2017 
Dietary risk of acute pancreatitis
 30 January 2017 
Care pathway for anemia in IBD 
 30 January 2017 
Mortality in elderly-onset IBD
 27 January 2017 
Therapeutic drug monitoring in IBD 
 27 January 2017 
Cancer mortality in the USA

Blackwell Publishing


GastroHep.com is a Blackwell Publishing registered trademark
© 2017 Wiley-Blackwell and GastroHep.com and contributors
Privacy Statement
Disclaimer
About Us